We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against the ...

Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma InterestProvidence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean ...

Biotech giant Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2024 results on Feb. 11, after ...

and lung cancer DPTX3496 is currently in IND-enabling studies and IND filing is planned for the second half of 2025 BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. – the ...

BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. – the leading ... negative breast cancer (TNBC), and non-small cell lung cancer (NSCLC). Based on the preclinical data ...

and lung cancer DPTX3496 is currently in IND-enabling studies and IND filing is planned for the second half of 2025 BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Dewpoint Therapeutics Inc. - the leading ...

and OSLO, Norway, Jan. 28, 2025 /PRNewswire/ -- Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, and EXACT Therapeutics (Euronext Growth: EXTX), a ...

Oncology is the key focus for Exact Therapeutics, spearheaded by our ongoing Phase 2 trial in locally advanced pancreatic cancer, which received IND clearance at the end of 2024.”, said Dr. Per Walday ...

MOUNTAIN VIEW, Calif. and OSLO, Norway, Jan. 28, 2025 /PRNewswire/ -- Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, and EXACT Therapeutics (Euronext ...